A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β(1)-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

OBJECTIVES AND BACKGROUND: The objective of this study was to investigate the image quality-improving and heart rate-lowering effects of landiolol hydrochloride (a short-acting β(1)-adrenergic receptor blocker) on coronary computed tomography angiography (CCTA). During CCTA, β-adrenergic receptor bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Masaharu, Yamashina, Akira, Hara, Kazuhiro, Ikari, Yuji, Jinzaki, Masahiro, Iino, Misako, Yamaguchi, Takuhiro, Tanimoto, Mitsunobu, Kuribayashi, Sachio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889825/
https://www.ncbi.nlm.nih.gov/pubmed/24174275
http://dx.doi.org/10.1007/s40261-013-0149-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889825/
https://www.ncbi.nlm.nih.gov/pubmed/24174275
http://dx.doi.org/10.1007/s40261-013-0149-y

Ejemplares similares